Enrico Picozza is the Chairman of the Council of Advisors and a pioneer in the life sciences with a history of recognizing and developing new technologies that change markets. He is currently a director of SensAble Technologies. Prior to joining HLM as a Venture Partner, Enrico co-founded HTS Biosystems, Inc., an early developer of platforms for drug discovery and point of care diagnostics, where he served as COO and CTO. Prior to HTS, Enrico held leadership positions with PerkinElmer, Inc. and Applied Biosystems, Inc. He is the holder of nine patents and has been recognized by the Smithsonian Institute for his achievements in PCR.